SMMT — Summit Therapeutics
Median target
$31
calls from the last 12 months
Implied return
+74.9%
median target vs. price
Coverage
17 analysts · 18 calls
updated in the last 12 months
Consensus
9/7/1+8 net
Buy / Hold / Sell
Which analysts are behind SMMT's consensus?
See every current rating, price target and the analysts' track records for Summit Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 17 analysts with calls on SMMT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.